Subcutaneous metastasis from a gastrointestinal stromal tumor of the stomach: A case report

Journal of B.U.ON.

Volumn 12, Issue 4, 2007, Pages 549-552

  Anagnostoulis, Stavros ^a,d   Mimidis, K ^b   Papadopoulos, V ^b   Papalazarou, D ^a   Argyropoulou, P ^a   Iakovidis, C ^a   Polychronidis, A ^b   Karayiannakis, A ^b   Filippou, D K ^c   Simopoulos, C ^b  

^a UNIVERSITY GENERAL HOSPITAL OF ALEXANDROUPOLIS   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d NONE   (Greece)

Author keywords

Gastrointestinal stromal tumors; Metastasis; Subcutaneous

Indexed keywords

CD34 ANTIGEN; FRESH FROZEN PLASMA; STEM CELL FACTOR RECEPTOR; VIMENTIN;

AGED; APONEUROSIS; ARTICLE; CASE REPORT; CHRONIC GASTRITIS; ERYTHROCYTE CONCENTRATE; FATALITY; FEMALE; GASTRECTOMY; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL STROMAL TUMOR; HEART ARREST; HEMATOCRIT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; PSYCHOSIS; RECTUS ABDOMINIS MUSCLE; STOMACH BIOPSY; STOMACH TUMOR; STOMACH ULCER; STOMACH WALL; SUBCUTANEOUS METASTASIS; SUBCUTANEOUS TISSUE; SUBCUTANEOUS TISSUE TUMOR; VOMITING;

AGED; FATAL OUTCOME; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; NEOPLASM METASTASIS; STOMACH NEOPLASMS; SUBCUTANEOUS TISSUE;

EID: 38349166690     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Connolly EM, Gaffney E, Reynolds JV. Gastrointestinal stromal tumours. Br J Surg 2003; 90: 1178-1186.
2. Sawaki A, Yamao K. Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors - a review. Cancer Chemother Pharmacol 2004; 54 (Suppl 1): 44-49.
3. Miettinen M, Lasota J. Gastrointestinal stromal tumors: definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001; 438: 1-12.
4. Shiu MH, Farr GH, Papachristou DN, Hajdu SI. Myosarcomas of the stomach: natural history, prognostic factors and management. Cancer 1982; 49: 177-187.
5. Ueyama T, Guo K-J, Hashimoto H, Daimaru Y, Enjoji M. A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer 1992; 69: 947-955.
6. Shabahang M, Livingstone AS. Cutaneous metastases from a gastrointestinal stromal tumor of the stomach: review of literature. Dig Surg 2002; 19: 64-65.
7. Mazur MT, Clark HB. Gastric stromal tumours. Reappraisal of histogenesis. Am J Surg Pathol 1983; 7: 507-519.
8. Miettinen M, Sobin L, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 2005; 9: 52-68.
9. Bucher P, Villiger P, Egger JF, Buhler LH, Morel P. Management of gastrointestinal stromal tumors: from diagnosis to treatment. Swiss Med Wkly 2004; 134: 145-53.
10. Graadt van Roggen JF, Van Velthuysen MLF, Hogendoorn PCW. The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol 2001; 54: 96-102.
11. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998; 11: 728-734.
12. Heinrich MC, Rubin BP, Longley BJ, Fletcher JA. Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenic alterations. Hum Pathol 2002; 33: 484-495.
13. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000; 231: 51-58.
14. Goss GS, Merriam P, Manola J, Singer S, Fletcher CD, Demetri GD. Clinical and pathological characteristics of gastrointestinal stromal tumours (GIST). Proc Am Soc Clin Oncol 2000; 19: s599 (abstr).